Retraction Note to: Antimicrobial misuse in pediatric urinary tract infections: recurrences and renal scarring (Annals of Clinical Microbiology and Antimicrobials, (2018), 17, 1, (27), 10.1186/s12941-018-0279-4);Antimicrobial misuse in pediatric urinary tract infections: Recurrences and renal scarring

Annals of Clinical Microbiology and Antimicrobials

Volumn 17, Issue 1, 2018, Pages

  Jayaweera, Jayaweera Arachchige Asela Sampath ^a   Reyes, Mohommed ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

Bio film; Childhood UTI; Emergence of resistance; Empiric antimicrobial; General practitioner; Recurrent pyelonephritis and renal scarring

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CARBAPENEM DERIVATIVE; CEFALOTIN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MEROPENEM; NITROFURANTOIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SUCCIMER; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOFILM; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; CHILD; DRUG MISUSE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GENERAL PRACTITIONER; HUMAN; INFANT; KIDNEY DISEASE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PYELONEPHRITIS; RECURRENT INFECTION; RENAL SCARRING; SRI LANKA; TERTIARY CARE CENTER; URINARY TRACT INFECTION; URINE CULTURE; ESCHERICHIA COLI INFECTION; GROWTH, DEVELOPMENT AND AGING; INAPPROPRIATE PRESCRIBING; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOLOGY; PRESCHOOL CHILD; RECURRENT DISEASE; SCAR;

ANTI-BACTERIAL AGENTS; BIOFILMS; CEFIXIME; CHILD; CHILD, PRESCHOOL; CICATRIX; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; INFANT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; PYELONEPHRITIS; RECURRENCE; URINARY TRACT INFECTIONS;

EID: 85049101873     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/s12941-021-00425-y     Document Type: Erratum

References (53)

1. Ma JF, Shortliffe LM. Urinary tract infection in children: etiology and epidemiology. Urol Clin North Am. 2004;31:517-26.
2. Rezaee MA, Abdinia B. Etiology and antimicrobial susceptibility pattern of pathogenic bacteria in children subjected to UTI. A referral hospital-based study in Northwest of Iran. Medicine. 2015;94(39):e1606.
3. Larcombe J. Urinary tract infection in children. BMJ. 1999;319:1173-5.
4. Alper BS, Curry SH. Urinary tract infection in children. Am Fam Phys. 2005;72:2483-8.
5. Elder JS, Behrman RE, Kliegman RM, Jenson HB, editors. Urologic disorders in infants and children. 1621-1625. Nelson textbook of pediatrics. 16th ed. Philadelphia: WB Saunders; 2000.
6. Urinary Tract Infections in Infants and Children in Developing Countries in the Context of IMCI. WHO. http://www.who.int/maternal_child_adolescent/documents/fch_cah_05_11/en. Accessed 12 Dec 2017.
7. Park YS. Renal scar formation after urinary tract infection in children. Korean J Pediatr. 2012;55(10):367-70.
8. Faust WC, Diaz M, Pohl HG. Incidence of post-pyelonephritic renal scarring: a meta-analysis of the dimercapto-succinic acid literature. J Urol. 2009;181:290-7.
9. Shaikh N, Ewing AL, Bhatnagar S, Hoberman A. Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics. 2010;126:1084-91.
10. Mackenzie JR, Murphy AV, Beattie TJ, Azmy AF. Guidelines for the management of acute urinary tract infection in childhood Report of a Working Group of the Research Unit, Royal College of Physicians. JRC Physicians. 1991;25(1):36-42.
11. Kurutepe S, Surucuoglu S, Sezgin C. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey. Jpn J Infect Dis. 2005;58:159-61.
12. Murray PR, Masur H. Current approaches to the diagnosis of bacterial and fungal bloodstream infections for the ICU. Crit Care Med. 2012;40(12):3277-82.
13. Montini G, Hewitt I. Urinary tract infections: to prophylaxis or not to prophylaxis? Pediatr Nephrol. 2009;24(9):1605-9.
14. Thomson KS, Sanders CC. Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob Agents Chemother. 1999;36:1877-82.
15. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18:1503-7.
16. Negi B, Kumar D, Kumbukgolla W, Jayaweera S, Ponnan P, Singh R, et al. Anti-methicillin resistant Staphylococcus aureus activity, synergism with oxacillin and molecular docking studies of metronidazole-triazole hybrids. Eur J Med Chem. 2016. https://doi.org/10.1016/j.ejmech.
17. Li B, Zhao Y, Liu C, Chen Z, Zhou D. Molecular pathogenesis of Klebsiella pneumoniae. Fut Microbiol. 2014;9(9):1071-81. https://doi.org/10.2217/fmb.14.48.
18. Definition of pyelonephritis. https://www.merriam-webster.com/dictionary/pyelonephritis. Accessed 12 Dec 2017.
19. Hooton T.M. Recurrent urinary tract infection. https://www.uptodate.com/contents/recurrent-urinary-tract-infection-in-women. Accessed 12 Dec 2017.
20. Wijesekara PNK, Kumbukgolla WW, Jayaweera JAAS, Rawat D. Review on usage of vancomycin in livestock and humans: maintaining its efficacy, prevention of resistance and alternative therapy. Vet Sci. 2017;4:6.
21. Tekgul S, Nijman JM, Hobeke K, Diagnosis and management of urinary incontinence in childhood. 2015; 703-12. https://www.ics.org/publications/ici/files-book/comite. Accessed 12 Jan 2017.
22. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG. IDSA Guidelines for treatment of uncomplicated acute bacterial cystitis and pyelonephritis in women. Clin Infect Dis. 2011;52:e103-20.
23. Isenberg HD. Clinical microbiology procedures handbook. 2nd ed. Washington DC: ASM press; 2004.
24. Taskinen S, Rönnholm K. Post-pyelonephritic renal scars are not associated with vesicoureteral reflux in children. J Urol. 2005;173(4):1345-8.
25. Trial Investigators RIVUR, Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014;370(25):2367-76.
26. Tapiainen T, Hanni AM, Salo J, Ikäheimo I, Uhari M. Escherichia coli biofilm formation and recurrences of urinary tract infections in children. Eur J Clin Microbiol Infect Dis. 2014;33(1):111-5.
27. Performance Standards for Antimicrobial Disk Susceptibility Tests. Clinical and Laboratory Standards Institute. M02-A11 (Approved Standard-Eleventh Edition); 2016.
28. Lee B, Kang SY, Kang HM, Yang NY, Kang H, Ha IS, Cheong HI, Lee HJ. Choi EH outcome of antimicrobial therapy of pediatric urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae. Infect Chemother. 2013;45(4):415-21.
29. Dortet L, Poirel L, Nordmann P. Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob Agents Chemother. 2012;56:6437-40.
30. ® 9.1.3 language reference: concepts. 3rd ed. Cary: SAS Institute Inc.; 2005.
31. Gupta P, Mandal J, Krishnamurthy S, et al. Profile of urinary tract infections in paediatric patients. Indian J Med Res. 2015;141(4):473-7.
32. Peters C, Rushton HG. Vesicoureteral reflux associated renal damage: congenital reflux nephropathy and acquired renal scarring. J Urol. 2010;184:265-73.
33. Lee YJ, Lee JH, Park YS. Risk factors for renal scar formation in infants with first episode of acute pyelonephritis: a prospective clinical study. J Urol. 2012;187:1032-6.
34. Orellana P, Baquedano P, Rangarajan V, Zhao JH, Eng ND, Fettich J, et al. Relationship between acute pyelonephritis, renal scarring, and vesicoureteral reflux: results of a coordinated research project. Pediatr Nephrol. 2004;19:1122-6.
35. Pecile P, Miorin E, Romanello C, Vidal E, Contardo M, Valent F, et al. Age-related renal parenchymal lesions in children with first febrile urinary tract infections. Pediatrics. 2009;124:23-9.
36. Jahnukainen T, Chen M, Celsi G. Mechanisms of renal damage owing to infection. Pediatr Nephrol. 2005;20:1043-53.
37. Wullt B, Bergsten G, Fischer H, Godaly G, Karpman D, Leijonhufvud I, et al. The host response to urinary tract infection. Infect Dis Clin North Am. 2003;17:279-301.
38. Lee JH, Son CH, Lee MS, Park YS. Vesicoureteral reflux increases the risk of renal scars: a study of unilateral reflux. Pediatr Nephrol. 2006;21:1281-4.
39. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589-603.
40. Murphy CN, Clegg S. Klebsiella pneumoniae and type 3 fimbriae: nosocomial infection, regulation and biofilm formation. Fut Microbiol. 2012;7(8):991-1002. https://doi.org/10.2217/fmb.12.74.
41. Roberts KB. Revised AAP guideline on UTI in febrile infants and young children. Am Fam Physician. 2012;86(10):940-6.
42. Ang JY, Ezike E, Asmar BI. Antibacterial resistance. Indian J Pediatr. 2004;71(3):229-39.
43. Degnan LA, Milstone AM, Diener-West M, Lee CKK. Extended-spectrum beta-lactamase bacteria from urine isolates in children. J Pediatr Pharmacol Ther. 2015;20(5):373-7.
44. Tillekeratne LG, Vidanagama D, Tippalagama R, Lewkebandara R, Joyce M, Nicholson BP, Nagahawatte A, Bodinayake CK, De Silva AD, Woods CW. Extended-spectrum ß-lactamase-producing Enterobacteriaceae as a common cause of urinary tract infections in Sri Lanka. Infect Chemother. 2016;48(3):160-5.
45. Dissayanake D, Fernando S, Chandrasiri N. The distribution and characteristics of extended-spectrum β-Lactamase producing Escherichia coli and Klebsiella species among urinary isolates in a tertiary care hospital. Sri Lankan J Infect Dis. 2005;2:30-6.
46. Chander A, Shrestha CD. Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal. BMC Res Notes. 2013;6:487.
47. Ullah AAG, Gohar IR. etiology and antibiotic resistance pattern of community-acquired urinary tract infections in children. KJMS. 2005;8(3):428.
48. Bajpai T, Pandey M, Varma M, Bhatambare GS. Prevalence of extended spectrum beta-lactamase producing uropathogens and their antibiotic resistance profile in patients visiting a tertiary care hospital in central India: implications on empiric therapy. Indian J Pathol Microbiol. 2014;57:407-12.
49. Moffett SE, Frazee BW, Stein JC, Navab B, Maselli J, Takhar SS, et al. Antimicrobial resistance in uncomplicated urinary tract infections in 3 California EDs. Am J Emerg Med. 2012;30(6):942-9.
50. Topaloglu R, Er I, Dogan BG, Bilginer Y, Ozaltin F, Besbas N, Ozen S, Bakkaloglu A, Gur D. Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr Nephrol. 2010;25(5):919-25.
51. Xiao YH, Wang J, Li Y. Bacterial resistance surveillance in China: a report from Mohnarin 2004-2005. Eur J Clin Microbiol Infect Dis. 2008;27:697-708.
52. Xiao YH, Shen P, Wei ZQ. Mohnrin report of 2010: surveillance of bacterial resistance in China. Chin J Nosocomiol. 2011;21:4896-902.
53. Jayaweera JA, Kumbukgolla WW. Antibiotic resistance patterns of methicillin-resistant Staphylococcus aureus (MRSA) isolated from livestock and associated farmers in Anuradhapura, Sri Lanka. Germs. 2017;7(3):132-9.